Remus Pharmaceuticals (NSE:REMUS) Revenue : ₹4,561 Mil (TTM As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Revenue?

Remus Pharmaceuticals's revenue for the six months ended in Sep. 2024 was ₹2,727 Mil. Its revenue for the trailing twelve months (TTM) ended in Sep. 2024 was ₹4,561 Mil. Remus Pharmaceuticals's Revenue per Share for the six months ended in Sep. 2024 was ₹462.81. Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ₹774.02.

During the past 12 months, the average Revenue per Share Growth Rate of Remus Pharmaceuticals was 1350.20% per year. During the past 3 years, the average Revenue per Share Growth Rate was 164.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, Remus Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 164.60% per year. The lowest was 164.60% per year. And the median was 164.60% per year.

Remus Pharmaceuticals Revenue Historical Data

The historical data trend for Remus Pharmaceuticals's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Revenue Chart

Remus Pharmaceuticals Annual Data

Trend

Mar20

Mar21

Mar22

Mar24

Revenue

119.19

184.18

247.17

2,125.00

Remus Pharmaceuticals Semi-Annual Data
	Mar20	Mar21	Mar22	Sep23	Mar24	Sep24
Revenue	Get a 7-Day Free Trial			-	-	290.41	1,834.59	2,726.85

Competitive Comparison of Remus Pharmaceuticals's Revenue

For the Medical Distribution subindustry, Remus Pharmaceuticals's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Remus Pharmaceuticals's Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Remus Pharmaceuticals's Revenue distribution charts can be found below:

* The bar in red indicates where Remus Pharmaceuticals's Revenue falls into.

Save Embed

;

Save Embed

;

Remus Pharmaceuticals Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹4,561 Mil.

Remus Pharmaceuticals (NSE:REMUS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Remus Pharmaceuticals Revenue Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054

Website

https://www.remuspharma.com

Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines